Peritoneal fluid concentrations of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta in women with pelvic adhesions

Fertil Steril. 2003 May;79(5):1168-75. doi: 10.1016/s0015-0282(03)00079-7.

Abstract

Objective: To establish whether the concentration of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1 (TIMP-1), and transforming growth factor-beta (TGF-beta) is influenced by the presence or absence of adhesions, and whether the concentration of these mediators vary throughout the menstrual cycle.

Design: Prospective case-control study.

Setting: Women undergoing laparoscopy in a university hospital in the United Kingdom.

Patient(s): Women undergoing laparoscopy for benign gynecological conditions.

Intervention(s): Samples of peritoneal fluid were collected at diagnostic laparoscopy in one group, and at laparoscopy and serially during the first 48 hours after laparoscopic adhesiolysis in a second group. We correlated the concentrations of mediators in serially sampled peritoneal fluid during the 48 hours following laparoscopic adhesiolysis to the adhesion formation and reformation found during second-look laparoscopy.

Main outcome measure(s): The concentrations of MMP-9, TIMP-1, and TGF-beta in peritoneal fluid.

Result(s): MMP-9 concentration was lower in the follicular phase than the luteal phase of the menstrual cycle. MMP-9 concentration was significantly lower in women with pelvic adhesions than in women with a normal pelvis. The MMP-9/TIMP-1 ratio is significantly higher in women with significant adhesions at second-look laparoscopy compared to women with minimal or no adhesions.

Conclusion(s): The components of extracellular matrix remodeling may play an important part in the adhesion formation/reformation process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Ascitic Fluid / chemistry*
  • Case-Control Studies
  • Female
  • Humans
  • Laparoscopy
  • Matrix Metalloproteinase 9 / analysis*
  • Middle Aged
  • Prospective Studies
  • Second-Look Surgery
  • Tissue Adhesions / metabolism*
  • Tissue Inhibitor of Metalloproteinase-1 / analysis*
  • Transforming Growth Factor beta / analysis*

Substances

  • Tissue Inhibitor of Metalloproteinase-1
  • Transforming Growth Factor beta
  • Matrix Metalloproteinase 9